| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8649347 | Cardiovascular Revascularization Medicine | 2018 | 5 Pages |
Abstract
In this real-world registry, A-SES and ZES seems to be associated with promising 1-year clinical safety outcomes following PCI in a contemporary cohort of high-risk diabetic patients. Our results should be considered hypothesis generating, as the clinical safety of A-SES has to be confirmed in a large trial.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Rik Rozemeijer, Daniela Benedetto, Adriaan O. Kraaijeveld, Michiel Voskuil, Mèra Stein, Leo Timmers, Saskia Z. Rittersma, Pierfrancesco Agostoni, Pieter A. Doevendans, Pieter R. Stella,